Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group

Lena Specht; Bouthaina Dabaja; Tim Illidge; Lynn D Wilson; Richard T Hoppe; International Lymphoma Radiation Oncology Group

doi:10.1016/j.ijrobp.2015.01.008

Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group

Lena Specht, Bouthaina Dabaja, Tim Illidge, Lynn D Wilson, Richard T Hoppe, International Lymphoma Radiation Oncology Group

Institut for Klinisk Medicin

86 Citationer (Scopus)

Abstract

Primary cutaneous lymphomas are a heterogeneous group of diseases. They often remain localized, and they generally have a more indolent course and a better prognosis than lymphomas in other locations. They are highly radiosensitive, and radiation therapy is an important part of the treatment, either as the sole treatment or as part of a multimodality approach. Radiation therapy of primary cutaneous lymphomas requires the use of special techniques that form the focus of these guidelines. The International Lymphoma Radiation Oncology Group has developed these guidelines after multinational meetings and analysis of available evidence. The guidelines represent an agreed consensus view of the International Lymphoma Radiation Oncology Group steering committee on the use of radiation therapy in primary cutaneous lymphomas in the modern era.

Originalsprog	Engelsk
Tidsskrift	International Journal of Radiation Oncology, Biology, Physics
Vol/bind	92
Udgave nummer	1
Sider (fra-til)	32-9
Antal sider	8
ISSN	0360-3016
DOI	https://doi.org/10.1016/j.ijrobp.2015.01.008
Status	Udgivet - 1 maj 2015

Adgang til dokumentet

10.1016/j.ijrobp.2015.01.008Licens: CC BY-NC-ND

Citationsformater

Specht, L., Dabaja, B., Illidge, T., Wilson, L. D., Hoppe, R. T., & International Lymphoma Radiation Oncology Group (2015). Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. International Journal of Radiation Oncology, Biology, Physics, 92(1), 32-9. https://doi.org/10.1016/j.ijrobp.2015.01.008

Modern radiation therapy for primary cutaneous lymphomas : field and dose guidelines from the International Lymphoma Radiation Oncology Group. / Specht, Lena; Dabaja, Bouthaina; Illidge, Tim et al.

I: International Journal of Radiation Oncology, Biology, Physics, Bind 92, Nr. 1, 01.05.2015, s. 32-9.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Specht, L, Dabaja, B, Illidge, T, Wilson, LD, Hoppe, RT & International Lymphoma Radiation Oncology Group 2015, 'Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group', International Journal of Radiation Oncology, Biology, Physics, bind 92, nr. 1, s. 32-9. https://doi.org/10.1016/j.ijrobp.2015.01.008

@article{a2a99676ccd54aff9493be75d640cb48,

title = "Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group",

abstract = "Primary cutaneous lymphomas are a heterogeneous group of diseases. They often remain localized, and they generally have a more indolent course and a better prognosis than lymphomas in other locations. They are highly radiosensitive, and radiation therapy is an important part of the treatment, either as the sole treatment or as part of a multimodality approach. Radiation therapy of primary cutaneous lymphomas requires the use of special techniques that form the focus of these guidelines. The International Lymphoma Radiation Oncology Group has developed these guidelines after multinational meetings and analysis of available evidence. The guidelines represent an agreed consensus view of the International Lymphoma Radiation Oncology Group steering committee on the use of radiation therapy in primary cutaneous lymphomas in the modern era.",

keywords = "Consensus, Humans, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides, Patient Positioning, Prognosis, Radiation Tolerance, Radiotherapy Dosage, Skin Neoplasms",

author = "Lena Specht and Bouthaina Dabaja and Tim Illidge and Wilson, {Lynn D} and Hoppe, {Richard T} and {International Lymphoma Radiation Oncology Group}",

year = "2015",

month = may,

day = "1",

doi = "10.1016/j.ijrobp.2015.01.008",

language = "English",

volume = "92",

pages = "32--9",

journal = "International Journal of Radiation Oncology, Biology, Physics",

issn = "0360-3016",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Modern radiation therapy for primary cutaneous lymphomas

T2 - field and dose guidelines from the International Lymphoma Radiation Oncology Group

AU - Specht, Lena

AU - Dabaja, Bouthaina

AU - Illidge, Tim

AU - Wilson, Lynn D

AU - Hoppe, Richard T

AU - International Lymphoma Radiation Oncology Group

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Primary cutaneous lymphomas are a heterogeneous group of diseases. They often remain localized, and they generally have a more indolent course and a better prognosis than lymphomas in other locations. They are highly radiosensitive, and radiation therapy is an important part of the treatment, either as the sole treatment or as part of a multimodality approach. Radiation therapy of primary cutaneous lymphomas requires the use of special techniques that form the focus of these guidelines. The International Lymphoma Radiation Oncology Group has developed these guidelines after multinational meetings and analysis of available evidence. The guidelines represent an agreed consensus view of the International Lymphoma Radiation Oncology Group steering committee on the use of radiation therapy in primary cutaneous lymphomas in the modern era.

AB - Primary cutaneous lymphomas are a heterogeneous group of diseases. They often remain localized, and they generally have a more indolent course and a better prognosis than lymphomas in other locations. They are highly radiosensitive, and radiation therapy is an important part of the treatment, either as the sole treatment or as part of a multimodality approach. Radiation therapy of primary cutaneous lymphomas requires the use of special techniques that form the focus of these guidelines. The International Lymphoma Radiation Oncology Group has developed these guidelines after multinational meetings and analysis of available evidence. The guidelines represent an agreed consensus view of the International Lymphoma Radiation Oncology Group steering committee on the use of radiation therapy in primary cutaneous lymphomas in the modern era.

KW - Consensus

KW - Humans

KW - Lymphoma, B-Cell

KW - Lymphoma, B-Cell, Marginal Zone

KW - Lymphoma, Large B-Cell, Diffuse

KW - Lymphoma, Large-Cell, Anaplastic

KW - Lymphoma, Non-Hodgkin

KW - Lymphoma, T-Cell, Cutaneous

KW - Mycosis Fungoides

KW - Patient Positioning

KW - Prognosis

KW - Radiation Tolerance

KW - Radiotherapy Dosage

KW - Skin Neoplasms

U2 - 10.1016/j.ijrobp.2015.01.008

DO - 10.1016/j.ijrobp.2015.01.008

M3 - Journal article

C2 - 25863751

SN - 0360-3016

VL - 92

SP - 32

EP - 39

JO - International Journal of Radiation Oncology, Biology, Physics

JF - International Journal of Radiation Oncology, Biology, Physics

IS - 1

ER -

Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater